Form 8-K - Current report:
SEC Accession No. 0001144204-17-063098
Filing Date
2017-12-11
Accepted
2017-12-11 14:51:48
Documents
5
Period of Report
2017-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv481072_8k.htm 8-K 22963
2 EXHIBIT 1.1 tv481072_ex1-1.htm EX-1.1 215730
3 EXHIBIT 5.1 tv481072_ex5-1.htm EX-5.1 6595
4 EXHIBIT 99.1 tv481072_ex99-1.htm EX-99.1 9034
5 EXHIBIT 99.2 tv481072_ex99-2.htm EX-99.2 9912
  Complete submission text file 0001144204-17-063098.txt   265667
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 171249331
SIC: 2836 Biological Products, (No Diagnostic Substances)